Overview Request Sample Pages Request Customization Download PDF
You are viewing: Rest Of Europe Companion Animal Diagnostic Market analysis

The Rest Of Europe Companion Animal Diagnostic Market was valued at $72.3 Million in 2026 and projected to reach to $99.4 Million by 2031, representing a compound annual growth rate of CAGR 6.6%. Rest Of Europe's companion animal diagnostic market is positioned for sustained expansion through 2031, with a 6.6% CAGR reflecting moderate but consistent growth.

Rest Of Europe Companion Animal Diagnostic Market (2026-2031) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

Rest Of Europe Companion Animal Diagnostic Market Trends and Insights

  • Rest Of Europe is experiencing steady growth driven by increasing pet ownership, rising awareness of preventive healthcare for companion animals, and advancing diagnostic technologies.
  • The region's veterinary sector is increasingly adopting point-of-care testing and laboratory diagnostics to improve animal health outcomes and operational efficiency. Rest Of Europe's market growth is supported by favorable regulatory environments and growing investment in veterinary infrastructure across smaller European markets.
  • Pet owners in Rest Of Europe are becoming more willing to invest in diagnostic services, reflecting broader trends toward premium pet care.
  • The forecast period through 2031 indicates sustained expansion as Rest Of Europe continues to align with Western European standards in companion animal healthcare and diagnostic capabilities..

Key Market Statistics

  • CAGR (2026-2031) CAGR 6.6%
  • Market Size, 2026 ~USD 72.3 Million
  • Forecast, 2031 ~USD 99.4 Million
  • Country Rest Of Europe

Rest Of Europe Companion Animal Diagnostic Market Overview

Market Valuation :

Rest Of Europe companion animal diagnostic market valued at USD 72.3 million in 2026, expanding to USD 99.4 million by 2031

Growth Trajectory :

Steady CAGR of 6.6% through 2031, driven by increasing pet ownership rates and growing consumer spending on animal healthcare across European nations

Key Growth Drivers :

Rising awareness of preventive healthcare for companion animals, adoption of advanced diagnostic technologies, and strengthening veterinary infrastructure in emerging European markets

Regional Dynamics :

Rest Of Europe demonstrates consistent demand for diagnostic services, supported by pet humanization trends and regulatory emphasis on animal welfare standards

Rest Of Europe Companion Animal Diagnostic Market Dynamics

  • The region benefits from increasing pet ownership, particularly in Central and Eastern European countries, coupled with rising disposable incomes and growing consumer awareness regarding preventive veterinary care.
  • Pet owners are increasingly investing in diagnostic services to ensure early disease detection and improved health outcomes for their animals. The market outlook remains positive as veterinary clinics modernize their diagnostic capabilities and adopt advanced technologies such as point-of-care testing and digital imaging.
  • Regulatory frameworks supporting animal health standards and the expansion of veterinary services in underserved markets will further accelerate growth.
  • However, regional variations in healthcare infrastructure and economic disparities may create uneven adoption rates across Rest Of Europe..

Related Ecosystem

Medical Devices

Top Technologies
  • Polymerase Chain Reaction (PCR)
  • Magnetic Resonance Imaging (MRI)
  • Disposable Autoinjectors
  • Pulse Oximeters
  • Blood Pressure Monitors
Top Companies
  • Medtronic plc
  • Abbott Laboratories
  • Stryker Corporation
  • Becton, Dickinson and Company
  • CONMED Corporation

    Key Takeaways

    • Rest Of Europe's companion animal diagnostic market will grow from USD 72.3 million (2026) to USD 99.4 million (2031) at a 6.6% CAGR.
    • Rest Of Europe is witnessing increased adoption of point-of-care and laboratory diagnostic technologies in veterinary practices.
    • Rising pet ownership and preventive healthcare awareness are primary growth drivers in Rest Of Europe.
    • Rest Of Europe's market expansion is supported by improving veterinary infrastructure and regulatory frameworks through 2031.

    Companion Animal Diagnostic Market Report Scope

    Report Metric Details
    Base Year 2026
    Fastest Growing Segment MOLECULAR DIAGNOSTICS (Technology)
    Forecast Period 2026–2031
    Growth Rate CAGR of 8.7% from 2026 to 2031
    Largest Segment CONSUMABLES (Product)
    Market Size Base Year (Billions) ~USD 3.56 (2026)
    Revenue Forecast (Billions) ~USD 5.4 (2031)
    Segments Covered Product, Technology, Type, Application, Animal Type, End User

    Rest Of Europe Companion Animal Diagnostic Market Report Segmentation

    6 segment dimensions are covered across the global market.

    By Product

    • Consumables
    • Instruments

    By Technology

    • Clinical Biochemistry
    • Hematology
    • Immunodiagnostics
    • Molecular Diagnostics
    • Other Technologies
    • Urinalysis

    By Type

    • Allergen-Specific Immunodiagnostic Tests
    • Blood Gas & Electrolyte Analysis
    • Blood Gas & Electrolyte Analyzers
    • Blood Gas & Electrolyte Reagents, Clips, And Cartridges
    • Blood Glucose Strips
    • Clinical Chemistry Analysis
    • Clinical Chemistry Analyzers
    • Clinical Chemistry Reagents, Clips, And Cartridges
    • Elisa Tests
    • Glucose Monitoring
    • Glucose Monitors
    • Hematology Analyzers
    • Hematology Cartridges
    • Immunoassay Analyzers
    • Lateral Flow Assays
    • Microarrays
    • Nucleic Acid Sequencing
    • Other Immunodiagnostics Products
    • Other Molecular Diagnostics Products
    • Pcr Tests
    • Radioimmunoassays
    • Rapid Tests
    • Strip Readers
    • Urinalysis Clips & Cartridges
    • Urine Analyzers
    • Urine Glucose Strips
    • Urine Test Strips

    By Application

    • Bacteriology
    • Clinical Pathology
    • Other Applications
    • Parasitology
    • Virology

    By Animal Type

    • Cats
    • Dogs
    • Horses
    • Other Companion Animals

    By End User

    • Home Care Settings
    • Veterinary Hospital & Clinics
    • Veterinary Reference Laboratories
    • Veterinary Research Institutes & Universities

    Target Audience

    • Veterinary Diagnostic Companies : Manufacturers and distributors of diagnostic equipment and services need Rest Of Europe-specific market data to develop regional expansion strategies and assess market penetration opportunities
    • Veterinary Clinic Operators : Clinic owners and veterinary practice managers require market insights to justify diagnostic technology investments and understand competitive positioning within Rest Of Europe's evolving landscape
    • Investment & Private Equity Firms : Investors evaluating opportunities in European veterinary healthcare need accurate Rest Of Europe market sizing and growth forecasts to assess portfolio companies and acquisition targets
    • Healthcare Consultants : Management consultants advising veterinary and animal health organizations require Rest Of Europe-specific data to develop market entry strategies and competitive analyses
    • Market Research Professionals : Analysts and researchers covering European healthcare and veterinary sectors need granular Rest Of Europe data to support comprehensive market reports and strategic recommendations

    Key Companies in the Rest Of Europe Companion Animal Diagnostic Market

    CompanyHQOwnershipStrongest segments
    MINDRAY MEDICAL INTERNATIONAL LIMITEDChinaPrivate CompanyPatient Monitoring and Life Support Products,In-Vitro Diagnostic Products,Medical Imaging Systems,
    QIAGEN NVNetherlandsPublic CompanySample technology consumables and instruments,Immune response and infectious disease diagnostics (incl. TB IGRA, transplant, viral load),Oncology, sexual and reproductive health assays,
    IDEXX LABORATORIES, INC.United StatesPublic CompanyCompanion Animal Group – in-clinic analyzers and SNAP rapid assays,Companion Animal Group – reference laboratories and telemedicine/consulting,Veterinary software, services, VetConnect PLUS and VetLab Station,
    FUJIFILM CORPORATIONJapanPublic CompanyHealthcare (medical devices, CDMO, pharma, regenerative medicine, cosmetics/supplements),Business Innovation (office equipment, document solutions, graphic communications, inkjet),Electronics (display, semiconductor materials, storage, industrial equipment, fine chemicals),
    THERMO FISHER SCIENTIFIC INC.United StatesPublic CompanyLife Sciences Solutions,Analytical Instruments,Specialty Diagnostics,
    BIOMéRIEUXFrancePublic CompanyClinical microbiology (culture media, VITEK 2, VITEK MS, AST including ETEST/VITEK REVEAL),Syndromic and molecular diagnostics (BIOFIRE, BIOFIRE SPOTFIRE, ARGENE, EMAG/NUCLISENS),Immunoassays and CLIA (VIDAS, Hybiome),
    BIONOTESouth KoreaPublic CompanyVeterinary fluorescence immunoassay and molecular diagnostics,Veterinary clinical biochemistry systems and reagents,Veterinary rapid immunoassay and ELISA kits,
    VIRBACFrancePublic CompanyCompanion-animal parasiticides and anti-infectives,Companion-animal specialty therapeutics & behavior (CKD diets, pheromones, mobility),Farm-animal vaccines (swine focus: Suigen range),

    MINDRAY MEDICAL INTERNATIONAL LIMITED

    Mindray Medical International Limited is a Chinese medical device manufacturer founded in 1991 with 8,400 employees. Operating as a private company, it specializes in diagnostic and monitoring equipment for healthcare applications.

    QIAGEN NV

    QIAGEN NV is a Dutch public company founded in 1984 with 5,500 employees. It provides molecular diagnostics, sample preparation, and life sciences research tools globally.

    IDEXX LABORATORIES, INC.

    IDEXX Laboratories, Inc. is a United States-based public company founded in 1983 with 11,000 employees. The company develops and manufactures diagnostic equipment and software for veterinary and water testing markets.

    FUJIFILM CORPORATION

    Fujifilm Corporation is a Japanese public company founded in 1934 with 73,526 employees. It operates across imaging, diagnostics, pharmaceuticals, and industrial products globally.

    THERMO FISHER SCIENTIFIC INC.

    Thermo Fisher Scientific Inc. is a United States public company founded in 1956 with 125,000 employees. It is a leading provider of laboratory equipment, reagents, and analytical instruments worldwide.

    BIOMéRIEUX

    bioMérieux is a French public company founded in 1963 with 14,894 employees. It specializes in in vitro diagnostics and microbiology testing solutions for clinical and industrial applications.

    BIONOTE

    BioNote is a South Korean public company founded in 2003 with 298 employees. The company develops and manufactures diagnostic devices and reagents for veterinary and clinical use.

    VIRBAC

    Virbac is a French public company founded in 1968 with 6,442 employees. It specializes in veterinary pharmaceuticals and animal health products.

    Reasons to Buy this Report

    • Regional Market Sizing : Accurate valuation data specific to Rest Of Europe (USD 72.3M in 2026) enables precise budget allocation and market entry strategies tailored to this distinct geographic segment
    • Growth Forecasting : 5-year forecast to 2031 with 6.6% CAGR provides reliable projections for business planning, investment decisions, and competitive positioning within Rest Of Europe's veterinary diagnostic sector
    • Regional Trend Analysis : Insights into Rest Of Europe-specific drivers including pet ownership patterns, preventive healthcare adoption, and diagnostic technology advancement inform localized go-to-market strategies
    • Competitive Intelligence : Understand Rest Of Europe market dynamics distinct from global trends, identifying regional opportunities and competitive gaps for veterinary diagnostic service providers and equipment manufacturers
    • Strategic Decision Support : Data-driven insights for Rest Of Europe enable informed decisions on market expansion, partnership development, and resource allocation within this moderately growing European segment

    Frequently asked questions

    What is the market size of companion animal diagnostics in Rest Of Europe in 2026?

    The companion animal diagnostic market in Rest Of Europe is valued at USD 72.3 million in 2026.

    What is the projected market size for Rest Of Europe by 2031?

    Rest Of Europe's companion animal diagnostic market is forecast to reach USD 99.4 million by 2031.

    What is the CAGR for Rest Of Europe's companion animal diagnostic market?

    Rest Of Europe's companion animal diagnostic market is expected to grow at a compound annual growth rate of 6.6% from 2026 to 2031.

    What are the main drivers of growth in Rest Of Europe's market?

    Key growth drivers in Rest Of Europe include rising pet ownership, increased awareness of preventive healthcare, advancing diagnostic technologies, and improving veterinary infrastructure.

    Which diagnostic technologies are gaining adoption in Rest Of Europe?

    Rest Of Europe is experiencing increased adoption of point-of-care testing and laboratory diagnostic solutions in veterinary practices.

    RESEARCH METHODOLOGY

    This research study extensively utilized both primary and secondary sources. It involved analyzing various factors influencing the industry to identify segmentation types, industry trends, key players, the competitive landscape, key market dynamics, and strategies employed by key players.

    Secondary Research

    This research study utilized a variety of comprehensive secondary sources, including directories, databases such as Bloomberg Business, Factiva, and Dun & Bradstreet, white papers, annual reports, company house documents, investor presentations, and SEC filings from various companies. Secondary research was employed to gather information crucial for an in-depth, technical, market-oriented, and commercial analysis of the companion animal diagnostics market. This approach also helped identify key players in the industry and allowed for classification and segmentation based on emerging trends at the most detailed level. Furthermore, significant developments pertaining to both market and technological perspectives were documented. A database of primary industry leaders was created as part of this secondary research.

    Primary Research

    In the primary research process, we interviewed a range of sources from both the supply and demand sides to gather qualitative and quantitative information for this report. Primary sources from the supply side include project/sales/marketing/business development managers, presidents, CEOs, vice presidents, chairpersons, chief operating officers, chief strategy officers, directors, chief information officers, and chief medical information officers related to the companion animal diagnostics market. Primary sources from the demand side include R&D product development teams in animal health companies, veterinary clinicians, diagnostic laboratory managers, and procurement heads at veterinary reference laboratories.

    Companion Animal Diagnostic Market Size, and Share

    Note: C-level executives include CEOs, COOs, CTOs, and VPs. Other designations include sales, marketing, and product managers.
    Tiers are defined based on a company’s total revenue. As of 2025: Tier 1 = >USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, and Tier 3 = <USD 500 million.

    To know about the assumptions considered for the study, download the pdf brochure

    Market Size Estimation

    The total size of the companion animal diagnostics market was determined through data triangulation across three approaches, as described below. After each approach, the weighted average of the three was calculated based on the level of assumptions used in each.

    Companion Animal Diagnostic Market Top Down and Bottom Up Approach

    Data Triangulation

    After arriving at the market size, the total market was divided into several segments and subsegments. Data triangulation and market breakdown procedures were employed as applicable to complete the overall market engineering process and obtain exact statistics for all segments and subsegments.

    Market Definition

    Companion animal diagnostics use plasma, serum, blood, urine, feces, and tissue samples to detect, monitor, and manage diseases and health conditions in dogs, cats, horses, and other household pets. The companion animal diagnostics market includes diagnostic instruments, test kits, reagents, and consumables used in veterinary clinics and laboratories, covering technologies such as clinical chemistry analyzers, hematology analyzers, immunodiagnostics and ELISA test kits, urinalysis systems, molecular diagnostic assays, glucose monitoring systems, and blood gas–electrolyte analyzers. These products support routine wellness screening, disease diagnosis, treatment monitoring, and preventive healthcare in companion animals.

    Key Stakeholders

    • Companion animal diagnostic manufacturers
    • Companion animal diagnostic distributors and suppliers
    • Companion animal R&D companies
    • Veterinary reference laboratories
    • Veterinary hospitals and clinics
    • Veterinary universities and research institutes
    • Government associations
    • Market research and consulting firms
    • Venture capitalists and investors
    • Distributors, channel partners, and third-party suppliers

    Report Objectives

    • To define, describe, segment, and forecast the companion animal diagnostics market by product, technology, application, animal type, end user, and region
    • To provide detailed information about the factors influencing market growth (such as drivers, restraints, opportunities, and challenges)
    • To analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall companion animal diagnostics market
    • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
    • To forecast the size of the companion animal diagnostics market in five main regions (along with their respective key countries): North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa
    • To profile the key players in the companion animal diagnostics market and comprehensively analyze their core competencies and market shares
    • To analyze competitive developments such as acquisitions, product launches, expansions, collaborations, agreements, and partnerships

    Available customizations:

    Based on the given market data, MarketsandMarkets offers customization to meet your company’s specific needs. The following customization options are available for the report:

    Company Information
    • Detailed analysis and profiling of additional market players (up to 5)
    Geographic Analysis
    • Further breakdown of the Rest of European companion animal diagnostics market into Austria, Finland, Switzerland, and other countries
    • Further breakdown of the Rest of Latin American companion animal diagnostics market into Colombia, Chile, and other countries
    Competitive Landscape Assessment
    • Market share analysis for North America and Europe, which provides market shares of the top 3–5 key players in the companion animal diagnostics market
    • Competitive leadership mapping for established players in the US

     

    Get the Full Companion Animal Diagnostic Market Report

    Full forecast, segment splits, and company analysis for all Companion Animal Diagnostic Market.

    Download Sample Pages Buy Report

    METHODOLOGY

    Need a Tailored Report?

    Customize this report to your needs

    Get 10% FREE Customization

    Customize This Report
    Fact checked
    Cite this Research
    DMCA.com Protection Status